http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2331889-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2007-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2008-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd6955d72733c282c1d725c0939b9185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c0aca6589e595d842cf3f9f2de5f0e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc4f2a947640d955e09c0c348b69852a |
publicationDate | 2008-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2331889-C1 |
titleOfInvention | Method of obstructive jaundice diagnostics |
abstract | FIELD: medicine. n SUBSTANCE: in patient tears, cholestasis-indicating enzymes are determined, namely: alkaline phosphatase (APh), γ-glutamiltranspeptidase (γ-GTP), leucinaminopeptidase (LAP). If APh activity is ≥ 400.0 nmol/(s·l) or more, γ-GTP is ≥ 700.0 nmol/(s·l) or more, LAP is ≥ 52.5 Unit/l, the obstructive character of jaundice is diagnosed. n EFFECT: method allows exclusion of invasive component in jaundice laboratory diagnostics, simplifies analyses completion, and quicken the diagnostics. n 1 tbl, 4 ex |
priorityDate | 2007-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 482.